Chemical Structure : ZSTK474
CAS No.: 475110-96-4
Catalog No.: PC-45869Not For Human Use, Lab Use Only.
ZSTK474 (ZSTK-474) is a potent inhibitor of class I PI3K isoforms with IC50 of 17 nM, 53 nM, and 6 nM for p110β, p110γ, and p110δ, respectively.
Packing | Price | Stock | Quantity |
---|---|---|---|
25 mg | $98 | In stock | |
50 mg | $148 | In stock | |
100 mg | $238 | In stock | |
250 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
ZSTK474 (ZSTK-474) is a potent inhibitor of class I PI3K isoforms with IC50 of 17 nM, 53 nM, and 6 nM for p110β, p110γ, and p110δ, respectively.
ZSTK474 (ZSTK474) shows potent antiproliferative activity against a panel of 39 human cancer cell lines with mean GI50 of 0.32 uM.
ZSTK474 (ZSTK474) is more effectively than that of LY294002 or wortmannin.
ZSTK474 (ZSTK474) induces apoptosis in OVCAR3 cells, and induces complete G1-phase arrest but not apoptosis in A549 cells at 10 uM.
ZSTK474 (ZSTK474) completely inhibits the growth of A549, PC-3, and WiDr xenografts in mice at 400mg/kg; and induces the regression of A549 xenograft tumors.
M.Wt | 417.4125 | |
Formula | C19H21F2N7O2 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
1H-Benzimidazole, 2-(difluoromethyl)-1-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)- |
1. Yaguchi S, et al. J Natl Cancer Inst, 2006, 98(8), 545-556.
2. Kong D, et al. Cancer Sci, 2007, 98(10), 1638-1642.
3. Kong D, et al. Eur J Cancer, 2009, 45(5), 857-865.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright